InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JRL | Ann: Half Year Accounts | 06/03/19 | 0 | 143 | |||
|
|||||||
JRL | Ann: Lithium Exploration Target at McDermitt | 22/02/19 | 2 | 394 | |||
|
|||||||
JRL | Ann: Jindalee Expands US Lithium Footprint | 19/02/19 | 0 | 168 | |||
|
|||||||
JRL | Ann: Quarterly Cashflow Report | 31/01/19 | 0 | 96 | |||
|
|||||||
JRL | Ann: Quarterly Activities Report | 31/01/19 | 0 | 110 | |||
|
|||||||
JRL | Ann: Cleansing Statement | 12:12 | 0 | 184 | |||
|
|||||||
JRL | Ann: Appendix 3B | 12:07 | 0 | 110 | |||
|
|||||||
JRL | Ann: Change of Director's Interest Notice | 31/12/18 | 0 | 169 | |||
|
See All Discussions